Clinical efficacy and safety of vortioxetine as an adjuvant drug for patients with bipolar depression
Journal of Zhejiang University-SCIENCE B · 2025-01 · 26 (1) · 26-38
DOI: 10.1631/jzus.b2400470 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Zhejiang University-SCIENCE B, online erschienen am 20.01.2025. Verfasst von Chunxiao Dai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. Hauptthemen laut MEDLINE: Bipolar Disorder, Vortioxetine, Sulfides. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Construction Fund of Key Medical Disciplines of Hangzhou, the National Key Research and Development Program of China, the Zhejiang Provincial Key Research and Development Program.
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
- Department of Clinical Psychology, Hangzhou First People's Hospital, Hangzhou 310006, China.
- Department of Clinical Pharmacy, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
- Fuyang Third People's Hospital, Hangzhou 311402, China.
- Department of Clinical Psychology, Hangzhou First People's Hospital, Hangzhou 310006, China. srxjian@163.com.
- Department of Clinical Pharmacy, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. srxjian@163.com.
Förderung
- the Construction Fund of Key Medical Disciplines of Hangzhou
- the National Key Research and Development Program of China
- the Zhejiang Provincial Key Research and Development Program
- the Research Project of Jinan Microecological Biomedicine Shandong Laboratory
- the Leading Talent of Scientific and Technological Innovation‒"Ten Thousand Talents Program" of Zhejiang Province
- the Innovation Team for Precision Diagnosis and Treatment of Major Brain Diseases
- the Chinese Medical Education Association
Zitieren
APA
Dai, C., Fu, Y., Li, X., Lin, M., Li, Y., Li, X., Huang, K., Zhou, C., Xie, J., Zhao, Q., & Hu, S. (2025). Clinical efficacy and safety of vortioxetine as an adjuvant drug for patients with bipolar depression. Journal of Zhejiang University-SCIENCE B, 26(1), 26-38. https://doi.org/10.1631/jzus.b2400470
Vancouver
Dai C, Fu Y, Li X, Lin M, Li Y, Li X, et al. Clinical efficacy and safety of vortioxetine as an adjuvant drug for patients with bipolar depression. Journal of Zhejiang University-SCIENCE B. 2025;26(1):26-38. doi:10.1631/jzus.b2400470
BibTeX
@article{Dai2025,
author = {Dai, Chunxiao and Fu, Yaoyang and Li, Xuanwei and Lin, Meihua and Li, Yinbo and Li, Xiao and Huang, Keke and Zhou, Chengcheng and Xie, Jian and Zhao, Qingwei and Hu, Shaohua},
title = {Clinical efficacy and safety of vortioxetine as an adjuvant drug for patients with bipolar depression},
journal = {Journal of Zhejiang University-SCIENCE B},
year = {2025},
volume = {26},
number = {1},
pages = {26--38},
doi = {10.1631/jzus.b2400470}
}
EUVIMED